Liposomal targeting and drug delivery: Kinetic consideration

Advanced Drug Delivery Reviews

Volumn 19, Issue 3, 1996, Pages 425-444

  Harashima, H ^a   Kiwada, H ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Clearance; Drug delivery system; Intracellular targeting; Liposomes; Long circulating liposomes; Opsonin; Phagocytosis; Pharmacokinetics; Targeting

Indexed keywords

DRUG DOSAGE; DRUG INTERACTIONS; DRUG PRODUCTS; LIPIDS; PHARMACOKINETICS; TISSUE;

INTRACELLULAR TARGETING; LIPOSOMES; LONG CIRCULATING LIPOSOMES; OPSONIN; PHAGOCYTOSIS; TARGETING;

CONTROLLED DRUG DELIVERY;

CHOLESTEROL; DICETYL PHOSPHATE; DILAUROYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLCHOLINE; DOXORUBICIN; DRUG CARRIER; EPIRUBICIN; INULIN; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; VINCRISTINE;

DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG RELEASE; DRUG TARGETING; ENCAPSULATION; HUMAN; LIVER CELL; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PHARMACEUTICS; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; TUMOR;

EID: 0030580954     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(96)00012-9     Document Type: Review

References (135)

1. [1] Gregoriadis, G. and Florence, A.T. (1993) Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. Drugs 45, 15-28.
2. [2] Gabizon, A., Shiota, R. and Papahadjopoulos, D. (1989) Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J. Natl. Cancer Inst. 81, 1484-1488.
3. [3] Chonn, A. Semple, S.C. and Cullis, P.R. (1991) Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim. Biopys. Acta 1070, 215-222.
4. [4] Harashima, H., Kume, Y., Yamane, C. and Kiwada, H. (1993) Kinetic modelling of liposome degradation in blood circulation. Biopharm. Drug Dispos. 14, 265-270.
5. [5] Kume, Y., Yamane, C., Harashima, H. and Kiwada, H. (1991) Quantitative analysis of the stability of liposomes in blood in vivo. Xenobiot. Metab. Dispos. 6, 201-208.
6. [6] Harashima, H., Midori, Y., Ohshima, S., Yachi, K., Kikuchi, Y. and Kiwada, H. (1993) Kinetic analysis of tissue distribution of doxorubicin incorporated in liposomes in rats (II) Biopharm. Drug Dispos. 14, 595-608.
7. [7] Uchiyama, K., Nagayasu, A., Yamagiwa, Y. Nishida, T. Harashima, H. and Kiwada, H. (1993) Effect of the size and fluidity of liposomes on their accumulation in tumors: A presumption of their interaction with tumors. Int. J. Pharm. 121, 195-203.
8. [8] Pappenheimer, J.R., Renkin, E.M. and Borrero, L.M. (1951) Filtration, diffusion and molecular sieving through peripheral capillary membranes. A contribution to the pore theory of capillary permeability. Am. J. Physiol. 167, 13-46.
9. [9] Rippe, B. and Haraldsson, B. (1994) Transport of macromolecules across microvascular walls: The two pore theory. Physiol. Rev. 74, 163-219.
10. [10] Hwang, K.J., Luk, K.F.S. and Beaumier, P.L. (1982) Volume of distribution and transcapillary passage of small unilamellar vesicles. Life Sci. 31, 949-955.
11. [11] Juliano, R.L. and Stamp, D. (1975) The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem. Biophys. Res. Commun. 63: 651-658.
12. [12] Gregoriadis, G. and Senior, J. (1980) The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Lett. 119, 43-46.
13. [13] Senir, J. and Gregoriadis, G. (1982) Is half-life of circulating liposomes determined by changes in their permeability? FEBS Lett. 145, 109-114.
14. [14] Kirby, C., Larke, J. and Gregoriadis, G. (1980) Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J. 186, 591-598.
15. [15] Kirby, C. and Gregoriadis, G. (1980) The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in vivo. Life Sci. 27, 2223-2230.
16. [16] Scherphof, G., Roerdink, F., Waite, M. and Parks, J. (1978) Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim. Biophys. Acta 542, 296-307.
17. [17] Tomlilnson, S. (1993) Complement defense mechanisms. Curr. Opin. Immunol. 5, 83-89.
18. [18] Harashima, H., Sakata, K., Funato, K. and Kiwada, H. (1994) Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm. Res. 11, 402-406.
19. [19] Chonn, A., Cullis, P.R. and Devine, D. (1991) The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146, 4234-4241.
20. [20] Funato, K., Yoda, R. and Kiwada, H. (1992) Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim. Biophys. Acta 1103, 198-204.
21. [21] Devine, D., Wong, K., Serrano, K.A., Chonn, A. and Cullis, P.R. (1994) Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta 1191, 43-51.
22. [22] Chonn, A., Semple, S.C. and Cullis, P.R. (1992) Association of blood proteins with large unilamellar liposomes in vivo: relation to circulation lifetimes. J. Biol. Chem. 267, 18759-18765.
23. [23] Harashima, H., Ochi, Y. and Kiwada, H. (1994) Kinetic modelling of liposome degradation in serum: Effect of size and concentration of liposomes in vitro. Biopharm. Drug Dispos. 15, 217-225.
24. [24] Harashima, H., Hiraiwa, T., Ochi, Y. and Kiwada, H. (1995) Size dependent liposome degradation in blood: In vivo/in vitro correlation by kinetic modelling. J. Drug Target. 9, 253-261.
25. [25] Mayer, L.D., Tai, L.C.K., Ko, D.S.C., Masin, D., Ginsberg, R.S., Cullis, P.R. and Bally, M.B. (1989) Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 49, 5922-5930.
26. [26] Boman, N.L., Mayer, L.D. and Cullis, P.R. (1993) Optimization of the retention properties of vincristine in liposomal systems. Biochim. Biophys. Acta 1152, 253-258.
27. [27] Boman, N.L., Masin, D., Mayer, L.D., Cullis, P.R. and Bally, M.B. (1994) Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. Cancer Res. 54, 2830-2833.
28. [28] Juliano, R.L. (1988) Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions. Adv. Drug Deliv. Rev. 2, 31-54.
29. [29] Wileman, T., Harding, C. and Stahl, P. (1985) Receptor mediated endocytosis. Biochem. J. 232, 1-14.
30. [30] Brown, E.J. (1991) Complement receptors and phagocytosis. Curr. Opin. Immunol. 3, 76-82.
31. [31] Patel, H.M. (1992) Serum opsonins and liposomes: Their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carr. Syst. 9, 39-90.
32. [32] Allen, T.M., Austin, G.A., Chonn, A., Lin, L. and Lee, K.C. (1991) Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim. Biophys. Acta 1061, 56-64.
33. [33] Senior, J. and Gregoriadis, G. (1982) Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid and cholesterol components. Life Sci. 30, 2123-2136.
34. [34] Patel, H.M., Tuzel, N.S. and Ryman, B.E. (1983) Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen. Biochim. Biophys. Acta 761, 142-151.
35. 3H]methotrexate with thioglycollate elicited macrophages in-vitro. J. Pharm. Pharmacol. 40, 171-175.
36. [36] Moghimi, S.M. and Patel, H.M. (1988) Tissue specific opsonins for phagocytic cells and their different affinity for cholestero-rich liposomes. FEBS Lett. 233, 143-147.
37. [37] Moghimi, S.M. and Patel, H.M. (1989) Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. Biochim. Biophys. Acta 984, 384-387.
38. [38] Rahman, Y.E., Cerny, E.A., Patel, K.R., Lau, E.H. and Wright, B.J. (1982) Differential uptake of liposomes varying in size and lipid composition by parenchymal and Kupffer cells of mouse liver. Life Sci. 31, 2061-2071.
39. [39] Spanjer, H.H., Galen, M., Roerdink, F.H., Regts, J. and Scherphof, G.L. (1986) Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition. Biochim. Biophys. Acta 863, 224-230.
40. [40] Gregoriadis, G. and Neerunjun, D.E. (1975) Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications. Eur. J. Biochem. 47, 179-185.
41. [41] Souhami, R., Patel, H.M. and Ryman, B.E. (1981) The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochim. Biophys. Acta 674, 354-371.
42. [42] Hsu, M.J. and Juliano, R.L. (1982) Interactions of liposomes with the reticuloendothelial system. II: Non-specific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. Biophys. Acta 7211, 411-419.
43. [43] Roerdink, F., Dijkstra, J., Hartman, G., Bolscher, B. and Scherphof, G. (1981) The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effect of lanthanum and gadolinium salts. Biochim. Biophys. Acta 677, 79-89.
44. [44] Allen, T.M. and Everest, J.M. (1983) Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. J. Pharmacol. Exp. Ther. 226, 539-544.
45. [45] Senior, J., Crawley, J.C. and Gregoriadis, G. (1985) Tissue distribution of liposomes exhibiting lung half-lives in the circulation after intravenous injection. Biochim. Biophys. Acta 839, 1-8.
46. [46] Beaumier, P.L. and Hwang, K.J. (1983) Effects of liposome size on the degradation of bovine brain sphingomyelin/cholesterol liposomes in the mouse liver. Biochim. Biophys. Acta 731, 23-30.
47. [47] Chow, D.D., Essien, H.E., Padki, M.M. and Hwang, K.J. (1989) Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect. J. Pharm. Exp. Ther. 248, 506-513.
48. [48] Cunningham, C.M., Kingzette, M., Richards, R.L., Alving, C.R., Lint, T.F. and Gewurz, H. (1979) Activation of human complement by liposomes: A model for membrane activation of the alternative pathway. J. Immunol. 122, 1237-1242.
49. [49] Okada, N., Yasuda, T., Tsumita, T. and Okada, H. (1982) Activation of the alternative complement pathway of guinea-pig by liposomes incorporated with trinitrophenylated phosphatidylethanolamine. Immunology 45, 115-124.
50. [50] Scieszka, J.F., Maggiora, L.L., Wright, S.D. and Cho, M.J. (1991) Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils. Pharm. Res. 8, 65-69.
51. [51] Liu, Z. and Hu, V.W. (1988) Fluorescence analysis of size distribution and mode of dye release from carboxyfluorescein-loaded vesicles: application to the study of complement-membrane interactions. Biochim. Biophys. Acta 945, 253-262.
52. [52] Wisse, E., De Zanger, R.B., Charels, K., Van Der Smisse, P. and McCuskey, R.S. (1985) The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 5, 683-692.
53. [53] McCuskey, R.S. and McCuskey, P.A. (1990) Fine structure and function of Kupffer cells. J. Elec. Microsc. Techn. 14, 237-246.
54. [54] Abra, R.M. and Hunt, C.A. (1981) Liposome disposition in vivo III. Dose and vesicle-size effects. Biochim. Biophys. Acta 666, 493-503.
55. [55] Beaumier, P.L., Hwang, K.J. and Slattery, J.T. (1983) Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from circulation. Res. Commun. Chem. Pathol. Pharmacol. 39, 277-289.
56. [56] Sato, Y., Kiwada, H. and Kato, Y. (1986) Effects of dose and vesicle size on the pharmacokinetics of liposomes. Chem. Pharm. Bull. 34, 4244-4252.
57. [57] Harashima, H., Yamane, C., Kume, Y. and Kiwada, H. (1993) Kinetic analysis of AUC-dependent saturable clearance of liposomes: Mathematical description of AUC dependency. J. Pharmacokin. Biopharm. 21, 299-308.
58. [58] Kume, Y., Maeda, F., Harashima, H. and Kiwada, H. (1991) Saturable, non-Michaelis-Menten uptake of liposomes by the reticuloendothelial system. J. Pharm. Pharmacol. 43, 162-166.
59. [59] Harashima, H., Kume, Y., Yamane, C. and Kiwada, H. (1992) Non-Michaelis-Menten type hepatic uptake of liposomes in the rat. J. Pharm. Pharmacol. 44, 707-712.
60. [60] Saba, T.M. (1970) Physiology and physiopathology of the reticuloendothelial system. Arch. Intern. Med. 126, 1031-1052.
61. [61] Harashima, H., Sakata, K. and Kiwada, H. (1993) Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake clearance of liposomes. Pharm. Res. 10, 606-610.
62. [62] Boxenbaum, H. (1982) Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J. Pharmacokin. Biopharm. 10, 201-227.
63. [63] Sawada, Y., Hanano, M., Sugiyama, Y., Harashima, H. and Iga, T. (1984) Prediction of the volume of distribution of basic drugs in humans based on data from animals. J. Pharmacokin. Biopharm. 12, 587-596.
64. [64] Mordenti, J., Chen, S.A., Moore, J.A., Ferraiolo, B.L. and Green, J.D. (1991) Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharm. Res. 8, 1351-1359.
65. [65] Harashima, H., Komatsu, S., Kojima, S., Yanagi, C., Morioka, Y., Naito, M. and Kiwada, H. (1996) Species difference in the disposition of liposomes among mice, rats and rabbits: Allometric relationship and species dependent: hepatic uptake mechanism. Pharm. Res., in press.
66. [66] Spanjer, H.H. and Scherphof, G.L. (1983) Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo. Biochim. Biophys. Acta 734, 40-47.
67. [67] Hara, T., Aramaki, Y., Tsuchiya, S., Hosoi, K. and Okada, A. (1987) Specific incorporation of asialofetuinlabeled liposomes into hepatocytes through the action of galactose-binding protein. Biopharm. Drug Dispos. 8, 327-339.
68. [68] Kolb-Bachofen, V. (1991) A membrane-bound form of the acute phase protein C-reactive protein is the galactose-specific particle receptor on rat liver macrophages. Pathobiology 59, 272-275.
69. [69] Kolb-Bachofen, V., Schlepper-Schaefer, J., Vogell, W. and Kolb, H. (1982) Electron microscopic evidence for an asialoglycoprotein receptor on Kupffer cells: Localization of lectin-mediated endocytosis. Cell 29, 859-866.
70. [70] Kolb-Bachofen, V. (1981) Hapatic receptor for asialoglycoproteins: Ultrastructural demonstration of ligand-induced microaggregation of receptors. Biochim. Biophys. Acta 645, 293-299.
71. [71] Schlepper-Schafer, J., Hulsmann, U., Djovkar, A., Meyer, H. E., Herbertz, L., Kolb, H. and Kolb-Bachofen, V. (1986) Endocytosis via galactose receptors in vivo. Exp. Cell Res. 165, 494-506.
72. [72] Tsuji, H., Osaka, S. and Kiwada, H. (1991) Targeting of liposomes surface-modified with glycyrrhizin to the liver. I. Preparation and biological disposition. Chem. Pharm. Bull. 39, 1004-1008.
73. [73] Osaka, S., Tsuji, H. and Kiwada, H. (1994) Uptake of liposomes surface-modified with glycyrrhizin by primary cultured rat hepatocytes. Biol. Pharm. Bull. 17, 940-943.
74. [74] Fidler, I.J. (1980) Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science 208, 1469-1471.
75. [75] Schroit, A.J. and Fidler, I.J. (1982) Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res. 42, 161-167.
76. [76] Fidler, I.J., Fogler, W.E., Kleinerman, E.S. and Saiki, I. (1985) Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-γ encapsulated in liposomes. J. Immunol. 135, 4289-4296.
77. [77] Barratt, G., Tenu, J.P., Yapo, A. and Peti, J.F. (1986) Preparation and characterisation of liposomes containing mannosylated phospholipids capable of targeting drugs to macrophages. Biochim. Biophys. Acta 862, 153-164.
78. [78] Muller, C.D. and Schuber, F. (1989) Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages. Biochim. Biophys. Acta 986, 97-105.
79. [79] Yamashita, C., Matsuo, H., Akiyama, K. and Kiwada, H. (1991) Enhancing effect of cetylmannoside on targeting of liposomes to Kupffer cells in rats. Int. J. Pharm. 70, 225-233.
80. [80] Yamashita, C., Sone, S., Ogura, T. and Kiwada, H. (1991) Potential value of cetylmannoside-modified liposomes as carriers of macrophage activators to human blood monocytes. Jpn. J. Cancer Res. 82, 569-576.
81. [81] Matsuo, H., Funato, K., Harashima,. H. and Kiwada, H. (1994) The complement-but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ. J. Drug Targ. 2, 141-146.
82. [82] Ferdous, A.J., Ishida, T., Shinohara, M., Harashima, H. and Kiwada, H. (1996) Size-dependent release of carboxy-fluorescein from cetylmannoside-modified liposomes in human plasma. Biopharm. Drug Disposit. 17, 145-154.
83. [83] Funato, K., Yamashita, C., Kamada, J., Tominaga, S. and Kiwada, H. (1994) Plasma factor triggering alternative complement pathway activation by liposomes. Pharm. Res. 11, 372-376.
84. [84] Allen, T.M. and Chonn, A. (1987) Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 223, 42-46.
85. [85] Gabizon, A. and Papahadjopoulos, U. (1988) Liposome formulation with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 85, 6949-6953.
86. [86] Woodle, M.C., Newman, M., Collins, L., Redemann, C. and Martin, F.J. (1990) Efficient evaluation of long-circulating or "stealth" liposomes by studied of in vivo blood circulation: kinetics and final organ distribution. Proc. Int. Symp. Control. Rel. Bioact. Mater. 17, 77-78.
87. [87] Klibanov, A.L., Maruyama, K., Torchilin, V.P. and Huang, L. (1990) Amphipatic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268, 235-237.
88. [88] Blume, G. and Cevc, C. (1990) Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta 1029, 91-97.
89. [89] Namba, Y., Sakakibara, T., Masada, M., Ito, F. and Oku, N. (1990) Glucuronate-modified liposomes with prolonged circulation time. Chem. Pharm. Bull. 38, 1663-1666.
90. [90] Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Yau-Young, A. (1991) Liposomes containing synthetic lipid derivatives of poly(ethyleneglycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066, 29-36.
91. [91] Woodle, M.C., Matthay, K.K., Newman, M.S., Hdayat, J.E., Collins, L.R., Redemann, C., Martin, F.J. and Papahadjopoulos, D. (1992) Versality in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim. Biophys. Acta 1105, 193-200.
92. [92] Allen, T.M. and Hansen, C. (1991) Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta 1068, 133-141.
93. [93] Lasic, D.D., Martin, F.J., Gabizon, A., Huang, S.K. and Papapadjopoulos, D. (1991) Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1070, 187-192.
94. [94] Torchilin, V.P., Omelyanenko, V.G., Papisov, M.I., Bogdanov, Jr. A.A., Trubetskoy, V.S., Herron, J.N. and Gentry, C.A. (1994) Poly(ethylen glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim. Biophys. Acta 1195, 11-20.
95. M1 on liposome circulation time: evidence supporting the dysopsonin hypothesis. Biochim. Biophys. Acta 1166, 105-114.
96. [96] Yamauchi, H., Yano, T., Kato, T., Tanaka, I., Nakabayashi, S., Higashi, K., Miyoshi, S. and Yamada, H. (1994) Effects of sialic acid derivative on long circulation time and tumor concentration of liposomes. Int. J. Pharm. 113, 141.
97. 1 shortens the blood circulation time of liposomes in rats. Pharm. Res. 12, 508-512.
98. [98] Klivanov, A.L., Maruyama, K., Becherleg, A.M., Torchilin, V.P. and Huang, L. (1991) In vivo studies of long circulating (Stealth) liposomes in rats. Period. Biol. 93, 349-352.
99. [99] Blume, G. and Cevc, G. (1993) Molecular mechanism of the lipid vesicle longevity in vivo. Biochim. Biophys. Acta 1146, 157-168.
100. [100] Woodle, M.C. and Lasic, D.D. (1992) Sterically stabilized liposomes. Biochim. Biophys. Acta 1113, 171-199.
101. [101] Peterson, H.M. and Applelgren, K.L. (1973) Experimental studies on the uptake and retention of labelled proteins in a rat tumor. Eur. J. Cancer 9, 543-547.
102. [102] Papadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.D., Woodle, M.C., Lasic, D.D., Redemann, C. and Martin, F.J. (1991) Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 88, 11460-11464.
103. [103] Huang, S.K., Lee, K-D., Hong, K., Friend, S.S. and Papahadjopoulos, D. (1992) Microscopic localization of Sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. 52, 5135-5143.
104. [104] Yuan, F., Leunig, M., Huang, S.K., Berk, D.A., Papahadjopoulos, D. and Jain, R.K. (1994) Microvascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res. 54, 3352-3356.
105. [105] Wu, N.Z., Da, D., Rudoll, T.L., Needham, D., Whorton, A.R. and Dewhirst, M.W. (1993) Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res. 53, 3765-3770.
106. [106] Fuse, E., Kobayashi, T., Inaba, M. and Sugiyama, Y. (1995) Prediction of the maximal tolerated dose (MTD) and therapeutic effect of anticancer drugs in human: integration of pharmacokinetics with pharmacodynamics and toxicodynamics. Cancer Treat. Rev. 21, 133-157.
107. [107] Storm, G., Roerdink, F.H., Steerenberg, P.A., de Jong, W.H. and Crommelin, D.J.A. (1987) Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res. 47, 3366-3372.
108. [108] Nagayasu, A., Shimooka, T., Kinouchi, Y., Uchiyama, K., Takeichi, Y. and Kiwada, H. (1994) Effects of fluidity and vesicle size on antitumor activity and myelosuppressive activity of liposomes loaded with daunorubicin. Biol. Pharm. Bull. 17, 935-939.
109. [109] Huang, S.K., Mayhew, E., Gilani, S., Lasic, D.D., Marin, F.J. and Papahadjopoulos, D. (1992) Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res. 52, 6774-6781.
110. [110] Suzuki, S., Watanabe, S., Uno, S., Tanaka, M., Masuko, T. and Hashimoto, Y. (1994) Endocytosis does not necessarily augment the cytotoxicity of adriamycin encapsulated in immunoliposomes. Biochim. Biophys. Acta 1224, 445-453.
111. [111] Mayer, L.D., Nayar, R., Thies, R.L., Boman, N.L., Cullis, P.R. and Bally, M.B. (1993) Identification of vesicle properties that enhance the antitumor activity of liposomal vincristine against murine L1210 leukemia. Cancer Chemother. Pharmacol. 33, 17-24.
112. [112] Mayer, L.D., Bally, M.B., Loughrey, H., Masin, D. and Cullis, P.R. (1990) Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors. Cancer Res. 50, 575-579.
113. [113] Weinstein, J.N., Yoshikami, S., Henkart, P., Bumenthal, R. and Hagins, W.A. (1977) Liposome-cell interaction: transfer and intracellular release of trapped fluorescent marker. Science, 195, 489-492.
114. [114] Raz, A., Bucana, C., Fogler, W.E., Poste, G. and Fidler, I.J. (1981) Biochemical, morphological, an ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res. 41, 487-494.
115. [115] Straubinger, R.M., Hong, K., Friend, D.S. and Papahadjopoulos, D. (1983) Endocytosis of liposomes and intracellular fate of encapsulate molecules: Encounter with a low pH compartment after internalization in coated vesicles. Cell 32, 1069-1079.
116. [116] Tietze, C., Schlesinger, P. and Stahl, P. (1982) Mannose specific endocytosis receptor of alveolar macrophages: Demonstration of two functionally distinct intracellular pools of receptor and their roles in receptor recycling. J. Cell Biol. 92, 417-424.
117. [117] Sugiyama, Y., Kim, D.C., Sato, H., Yanai, S., Satoh, H., Iga, T. and Hanano, M. (1990) Receptor-mediated disposition of polypeptides: Kinetic analysis of the transport of epidermal growth factor as a model peptide using in vitro isolated perfused organs and in vivo system. J. Control. Rel. 13, 157-174.
118. [118] Marshall, S. (1985) Dual pathways for the intracellular processing of insulin: Relationship between retroendocytosis of intact hormone and the recycling of insulin receptors. J. Biol. Chem. 260, 13524-13531.
119. [119] Straubinger, R.M., Papahadjopoulos, D. and Hong, K. (1990) Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochemistry 29, 4929-4939.
120. [120] Daleke, D., Hong, K. and Papahadjopoulos, D. (1990) Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim. Biophys. Acta 1024, 352-366.
121. [121] Mellman, I., Fuchs, R. and Helenius, A. (1986) Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55, 663-700.
122. [122] Yamashiro, D.J. and Maxfield, F.R. (1987) Acidification of morphologically distinct endosomes in mutant and wild-type chinese hamster ovary cells. J. Cell Biol. 105, 2723-2733.
123. [123] Gruenberg, J., Griffiths, G. and Howell, K.E. (1989) Characterization of the early endosome and putative endocytic carrier vesicles in vivo and with an assay of vesicle fusion in vitro. J. Cell Biol. 108, 1301-1316.
124. [124] Stoovogel, W., Strous, G.J., Geuze, H.J., Oorsschot, V. and Schwartz, A.L. (1991) Late endosomes derive from early endosomes by maturation. Cell 65, 417-427.
125. [125] Yoshimura, T., Shono, M., Imai, K. and Hong, K. (1995) Kinetic analysis of endocytosis and intracellular fate of liposomes in single macrophages. J. Biochem. 117, 34-41.
126. [126] Schmid, S.L., Fuchs, R.M., Male, P. and Mellman, I. (1988) Two distinct subpopulations of endosomes involved in membrane recycling and transport to lysosomes. Cell 52, 73-83.
127. [127] Derksen, J.T.P., Morselt, H.W.M. and Scherphof, G.L. (1987) Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim. Biophys. Acta 931, 33-40.
128. [128] Harashima, H., Hirai, N. and Kiwada, H. (1995) Kinetic modelling of liposome degradation in peritoneal macrophages. Biopharm. Drug Dispos. 16, 113-123.
129. [129] Morioka, Y., Harashima, H., Yoshimura, K. and Kiwada, H. (1996) The effect of liposomal dose on the intracellular fate of liposomes in rats in vivo. Drug Deliv. Syst. 11, 27-35.
130. [130] Roerdink, F.H., Regts, J., Handel, T., Sullivan, S.M., Baldeschwieler, J.D. and Scherphof, G.L. (1989) Effect of cholesterol on the uptake and intracellular degradation of liposomes by liver and spleen; a combined biochemical and γ-ray perturbed angular correlation study. Biochim. Biophys. Acta 980, 234-240.
131. [131] Verma, J.N., Wassef, N.M., Wirtz, R.A., Atkinson, C.T., Aikawa, M.A., Loomis, L.D. and Alving, C.R. (1991) Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen. Biochim. Biophys. Acta 1066, 229-238.
132. [132] Harding, C.V. and Geuze, H.J. (1993) Antigen processing and intracellular traffic of antigens and MHC molecules. Curr. Opin. Cell Biol. 5, 596-605.
133. [133] Connor, J. and Huang, L. (1985) Cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. J. Cell Biol. 101, 582-589.
134. [134] Zhou, F., Watkins, S.C. and Huang, L. (1994) Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes. Immunobiology 190, 35-52.
135. [135] Harding, C.V., Collins, D.S., Slot. J.W., Geuze, H.J. and Unanue, E.R. (1991) Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 64, 393-401.